PFA
LLY icon

Pathway Financial Advisers’s Eli Lilly LLY Stock Holding History

Pathway Financial Advisers’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.47M Buy
2,892
+101
+4% +$103K 0.87% 40
2026
Q1 		$2.57M Buy
2,791
+278
+11% +$282K 0.73% 50
2025
Q4 		$2.7M Sell
2,513
-23
-0.9% -$22K 0.78% 46
2025
Q3 		$1.88M Buy
2,536
+749
+42% +$557K 0.55% 64
2025
Q2 		$1.39M Buy
1,787
+123
+7% +$95.6K 0.45% 75
2025
Q1 		$1.37M Buy
1,664
+478
+40% +$398K 0.47% 72
2024
Q4 		$915K Buy
1,186
+1,185
+118,500% +$981K 0.31% 94
2024
Q3 		$1.15K Sell
1
-1,100
-100% -$989K ﹤0.01% 371
2024
Q2 		$982K Buy
1,101
+44
+4% +$35.2K 0.35% 90
2024
Q1 		$823K Buy
1,057
+82
+8% +$58.4K 0.3% 99
2023
Q4 		$568K Buy
975
+99
+11% +$57.8K 0.22% 114
2023
Q3 		$471K Buy
+876
New +$451K 0.19% 118
2023
Q1 		$323K Sell
940
-250
-21% -$84.3K 0.13% 139
2022
Q4 		$436K Buy
+1,190
New +$422K 0.18% 119

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pathway Financial Advisers's LLY Position: Q2 2026 in Review

Pathway Financial Advisers increased its Eli Lilly (LLY) stake by 3.6% in Q2 2026, buying an estimated $103K and bringing the position to 2,892 shares worth $3.47M. The position accounts for 0.87% of the portfolio, ranked #40.

Pathway Financial Advisers first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Pathway Financial Advisers held 2,892 shares of Eli Lilly worth $3.47M as of Q2 2026.
  • Pathway Financial Advisers bought 101 Eli Lilly shares in Q2 2026, an estimated $103K.
  • Eli Lilly made up 0.87% of Pathway Financial Advisers's portfolio in Q2 2026, its #40 holding.
  • Pathway Financial Advisers first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pathway Financial Advisers's 13F filing for Q2 2026, filed 30 Jul 2026.